| Old Articles: <Older 38581-38590 Newer> |
|---|
 |
The Motley Fool
October 20, 2009
Morgan Housel |
No Bueno, Citigroup Mexican regulators are ready to attack.   |
The Motley Fool
October 20, 2009
Chris Jones |
This Farmer Knows How to Grow Money Ron Muhlenkamp was raised on a farm, and he applies the lessons he learned growing up to investing. |
The Motley Fool
October 20, 2009
David Lee Smith |
Don't Miss the Return of Big Mining The big mining stocks spent the tail end of last week prominently displayed in the news. |
The Motley Fool
October 20, 2009
Anders Bylund |
Is Netflix Overvalued? This stock is soaring with the eagles -- but is Netflix worth its premium price tag? |
The Motley Fool
October 20, 2009
Toby Shute |
The Amazing Shale Race Unconventional gas is going global. |
The Motley Fool
October 20, 2009 |
Roundtable: Buy This Bank Three analysts, three bank picks. |
Registered Rep.
October 15, 2009
Christina Mucciolo |
Schwab Q3 Earning Down, But the Race For RIA Assets Is Hot Charles Schwab reported a 34 percent drop in its third quarter earnings, the firm's third consecutive quarter of slowing earnings this year. |
The Motley Fool
October 19, 2009
Rob Plaza |
Is Fairchild's Rally Over? Predictably, Fairchild Semiconductor's third-quarter results came in ahead of analyst estimates. Like other semiconductor companies, it benefited from improving customer demand and inventory restocking. But is the rally over? |
The Motley Fool
October 19, 2009
Rich Smith |
Harley-Davidson's Wildest Quarter Ever Over the long road, the firm only has so much debt to sell. Sooner or later, it needs to remember how to sell bikes. |
The Motley Fool
October 19, 2009
Rich Smith |
This Just In: Upgrades and Downgrades Merriman Curhan Ford thinks Geron could as much as double off today's price, primarily in response to successful data on GRN163L, a treatment that targets cancer agent telomerase. |
| <Older 38581-38590 Newer> Return to current articles. |
